Chart calendar Aastrom Biosciences Inc
Upcoming events on Aastrom Biosciences Inc
Past events on Aastrom Biosciences Inc
01/05/2024 14:00 | Annual General Meeting |
05/03/2024 16:10 | TD Cowen Health Care Conference |
29/02/2024 13:30 | Q4 2023 Earnings Call |
29/02/2024 12:55 | Q4 2023 Earnings Release |
12/02/2024 16:00 | Canaccord Genuity Musculoskeletal Conference |
10/01/2024 15:30 | JPMorgan Healthcare Conference |
15/11/2023 15:00 | Stephens Investment Conference |
08/11/2023 13:30 | Q3 2023 Earnings Call |
08/11/2023 12:55 | Q3 2023 Earnings Release |
12/09/2023 12:30 | Morgan Stanley Global Healthcare Conference |
02/08/2023 13:30 | Q2 2023 Earnings Call |
02/08/2023 12:55 | Q2 2023 Earnings Release |
10/05/2023 13:30 | Q1 2023 Earnings Call |
10/05/2023 12:55 | Q1 2023 Earnings Release |
03/05/2023 14:00 | Annual General Meeting |
07/03/2023 17:30 | Canaccord Genuity Musculoskeletal Conference |
23/02/2023 13:30 | FY 2022 Earnings Call |
23/02/2023 12:55 | FY 2022 Earnings Release |
11/01/2023 15:30 | JP Morgan Healthcare Conference |
17/11/2022 16:00 | Stephens Investment Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 118 117 0.35% | 124 124 0.17% | 156 157 -0.32% | 164 165 -0.16% | 198 197 0.01% | 239 |
EBITDA Million USD | Released Forecast Spread | -9,51 -10,5 9.46% | 18,6 16,7 10.99% | 29,5 32,0 -7.86% | 24,2 22,6 6.9% | 33,9 30,7 10.29% | 48,5 |
EBIT Million USD | Released Forecast Spread | -11,3 -11,5 2.23% | 2,37 0,04 6354.42% | -7,85 -5,61 -39.94% | -17,1 -21,4 20.3% | -6,46 -10,2 36.88% | 5,36 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,67 -10,3 5.89% | 3,04 1,05 190.64% | -7,58 -4,23 -79.37% | -16,0 -20,8 23.27% | -2,37 -7,32 67.65% | 6,72 |
Net income Million USD | Released Forecast Spread | -9,67 -10,4 6.9% | 2,86 0,49 479.46% | -7,47 -5,39 -38.6% | -16,7 -20,9 20.12% | -3,18 -7,63 58.28% | 4,27 |
EPS USD | Released Forecast Spread | -0,22 -0,23 5.04% | 0,06 0,01 700% | -0,16 -0,12 -37.93% | -0,35 -0,44 21.17% | -0,07 -0,16 56.25% | 0,08 |
Announcement Date | 25/02/20 | 24/02/21 | 24/02/22 | 23/02/23 | 29/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 47,6 48,1 -1.03% | 36,1 34,3 5.16% | 37,0 38,3 -3.39% | 38,6 39,9 -3.38% | 52,7 53,0 -0.5% | 41,0 37,4 9.76% | 45,9 42,1 9% | 45,6 45,1 0.96% | 65,0 65,0 0.03% | 49,1 | 54,3 | 57,0 | 78,8 | 60,3 |
EBITDA Million USD | Released Forecast Spread | 12,8 15,3 -16.54% | 3,24 4,14 -21.71% | 2,77 5,20 -46.7% | 3,33 6,08 -45.32% | 14,9 13,4 10.85% | 1,70 4,72 -63.96% | 4,44 2,52 76.11% | 5,44 4,31 26.25% | 22,3 19,1 16.56% | 4,74 | 7,17 | 8,49 | 28,1 | 11,2 |
EBIT Million USD | Released Forecast Spread | 4,14 6,39 -35.15% | -7,27 -4,55 -59.84% | -9,08 -5,95 -52.59% | -6,79 -4,91 -38.37% | 6,09 1,74 249.15% | -8,18 -7,51 -8.87% | -5,96 -7,36 19.04% | -5,06 -6,15 17.71% | 12,7 9,00 41.42% | -5,49 | -2,68 | -1,49 | 15,0 | -0,25 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4,21 7,57 -44.38% | -7,09 -4,21 -68.31% | -8,96 -5,87 -52.76% | -6,56 -4,73 -38.69% | 6,62 1,77 274% | -7,50 -7,41 -1.09% | -5,02 -7,75 35.2% | -3,95 -5,99 34.12% | 14,1 9,20 53.25% | -5,17 | -2,33 | -1,14 | 15,4 | 0,09 |
Net income Million USD | Released Forecast Spread | 4,54 6,60 -31.24% | -7,09 -3,79 -86.99% | -8,96 -5,79 -54.89% | -6,58 -4,84 -35.96% | 5,92 1,72 244.18% | -7,50 -7,41 -1.09% | -5,02 -7,29 31.1% | -3,66 -5,75 36.38% | 13,0 8,59 51.3% | -5,33 | -2,65 | -1,07 | 13,3 | -0,08 |
EPS USD | Released Forecast Spread | 0,09 0,14 -34.78% | -0,15 -0,12 -28.57% | -0,19 -0,12 -55.74% | -0,14 -0,10 -37.25% | 0,13 0,04 261.11% | -0,16 -0,15 -4.35% | -0,11 -0,15 27.63% | -0,08 -0,12 34.25% | 0,26 0,17 54.76% | -0,11 | -0,06 | -0,02 | 0,26 | -0,03 |
Announcement Date | 24/02/22 | 04/05/22 | 03/08/22 | 09/11/22 | 23/02/23 | 10/05/23 | 02/08/23 | 08/11/23 | 29/02/24 | - | - | - | - | - |
Today 12:00 | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
06/05/2024 | BIOTEST AG: Q1 2024 Earnings Release |
06/05/2024 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
06/05/2024 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
07/05/2024 07:00 | BIOGAIA AB: Q1 2024 Earnings Release |
07/05/2024 12:30 | INTRA-CELLULAR THERAPIES, INC.: Q1 2024 Earnings Release |
07/05/2024 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
07/05/2024 | ZAI LAB LIMITED: Q1 2024 Earnings Release |
08/05/2024 12:55 | VERICEL CORPORATION: Q1 2024 Earnings Release |
08/05/2024 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
Past sector events for Aastrom Biosciences Inc
02/05/2024 21:05 | TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release |
02/05/2024 12:50 | ARBUTUS BIOPHARMA CORPORATION: Q1 2024 Earnings Release |
02/05/2024 12:30 | BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release |
01/05/2024 | SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release |
30/04/2024 12:00 | INCYTE CORPORATION: Q1 2024 Earnings Release |
29/04/2024 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release |
29/04/2024 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release |
29/04/2024 | BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release |
29/04/2024 22:53 | SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release |
28/04/2024 | SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release |